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Differentiated neurons retain the capacity to generate axons
from dendrites
Frank Bradke* and Carlos G. Dotti†‡
Cutting the axon of a morphologically polarized
neuron (stage 3) close to the cell body causes another
neurite to grow as an axon [1–3]. Stage 3 neurons still
lack molecular segregation of axonal and dendritic
proteins, however. Axonal and dendritic compartments
acquire their distinct composition at stage 4 (4–5 days
in culture), when proteins such as the microtubule-
associated protein 2 (MAP-2) and the glutamate
receptor subunit GluR1 localize to the dendrites and
disappear from the axon [4,5]. We investigated
whether cultured hippocampal neurons retained
axon/dendrite plasticity after axons and dendrites
have created their distinct cytoskeletal architecture
and acquired their specific membrane composition.
We found that axotomy of stage 4 neurons
transformed a dendrite into an axon. Using axonal and
dendritic markers, we tested whether cytoskeletal
changes could cause similar transformations, and
found that actin depolymerization induced multiple
axons in unpolarized neurons. Moreover, depletion of
actin filaments from both morphologically and
molecularly polarized cells also resulted in the growth
of multiple axons from pre-existing dendrites. These
results imply that dendrites retain the potential to
become axons even after molecular segregation has
occurred and that the dendritic fate depends on the
integrity of the actin cytoskeleton.
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Results and discussion
We first performed axotomy on stage 4 cells. The axon of
stage 4 cells is often difficult to identify because it inter-
mingles with the axons from other cells. We thus observed
stage 3 cells on a grid to identify the axon unambigu-
ously (Figure 1a, arrows), then incubated them for a
further 2 days before observing them again at stage 4. At
the second observation, the axon had grown extensively,
becoming thin and constant in diameter from the cell
body to the tip (Figure 1b, arrows), and the dendrites had
acquired their typical tapered appearance (Figure 1b,
arrowheads) [6]. As expected, control cells segregated the
axonal marker Tau-1 to the axon and the dendritic marker
MAP-2 to dendrites (Figure 2a–d). We cut the axon of
such a cell close to the cell body (Figure 1c, thick arrow)
and analyzed its morphology 24 hours later. In the example
shown in Figure 1, the former axon regrew only 15 µm
after axotomy within 24 hours, and became thicker and
tapered distally, resembling a dendrite by morphological
criteria (Figure 1d, arrow). In contrast, one dendrite changed
its shape from a tapering structure (Figure 1c, arrowheads)
to a long thin process resembling an axon by morphologi-
cal criteria (Figure 1d, arrowheads).
Immunocytochemistry confirmed that the cut axon had
acquired dendritic properties. It showed reduced staining
for Tau-1 and became positive for MAP-2 (Figure 1e,f,
arrow). In contrast, the dendrite that had changed its shape
became Tau-1 positive in a characteristic proximal–distal
gradient [7] and showed only some MAP-2 staining in a
20 µm long proximal region (Figure 1f, arrowheads). This
led us to conclude that the former dendrite had become an
axon. Other Tau-1-positive axons grew near the axotomized
cell. Low-intensity microscopy through different focal
planes showed that two axons, labeled 1 and 2 in Figure 1g,
do not originate from the cell body of the observed cell but
cross it (data not shown). It cannot be ruled out, however,
that the axon numbered 3 is a putative second axon origi-
nating from the axotomized cell (Figure 1g). In 15 out of 18
experiments the cut axon became the dendrite and another
dendrite became an axon.
The axon of a stage 4 cell thus can reverse its fate and
become a dendrite and a dendrite can become an axon
even after the segregation of axonal and dendritic proteins
to their appropriate compartments. What mechanism
could allow such flexibility? We recently showed that
addition of the actin-depolymerizing drug cytochalasin D
to stage 2 neurons, in which neurites are still indistin-
guishable from each other, resulted in the growth of numer-
ous neurites with morphological axonal-like properties
instead of the typical differentiation of one axon and
several dendrites [8]. Could actin depolymerization also
lead to axon formation in cells that had already established
polarity? First, we investigated whether the processes of
stage 2 neurons grown in the presence of actin-depolymer-
izing agents become axons as judged by molecular criteria
or are dendrites with axonal growth rates. Actin depoly-
merization was induced by cytochalasin D, latrunculin B
or bacterial toxin B.
Stage 2 neurons were treated with cytochalasin D or
DMSO for 5 days, fixed and stained for the axonal
markers Tau-1 and the growth-associated protein 43
(GAP-43) [7,9,10] and the dendritic marker MAP-2 [5].
Cytochalasin D treatment disassembled the actin cytoskele-
ton in the neurites compared with control cells (data not
shown). In control neurons, Tau-1 and GAP-43 segregated
into a single axon (Figure 2a, arrow) and MAP-2 localized
to the dendrites (Figure 2b, arrowhead). This complemen-
tary distribution had already occurred after 4–5 days in
culture (stage 4). Less than 15% of untreated or DMSO-
treated neurons contain two axons [6,8]. In contrast to
control cells, cytochalasin-D-treated neurons have Tau-1
in multiple processes (2–6) in 75.3 (± 2.5)% of the cases
(n = 1697) (Figure 2e, arrows) whereas MAP-2 was
retained in the proximal part of the neurites (Figure 2f,
arrowhead). Neurites often became longer than 200 µm.
Latrunculin B treatment caused 86.4 (± 4.0)% of the cells
(n = 410) to form multiple (2–6) Tau-1-positive neurites.
Similarly, treatment of unpolarized cells (stage 2) with
toxin B induces multiple Tau-1-positive axons per cell
in 74.5 (± 3.4)% of the treated neurons (n = 505) (data not
shown). In independent experiments, 80.7 (± 2.5)% of
cytochalasin-D-treated cells have at least two, but more
commonly three to six, processes that are GAP-43 posi-
tive (n = 495) (data not shown). Treating cells with the
actin-stabilizing drug jasplakinolid [11,12] for 24 hours
suppressed axonal elongation. Longer treatment led to
extensive cell death (data not shown).
Actin filament depletion thus causes neurons to become
multiaxonal cells, as indicated by the localization of typical
axonal and dendritic markers. The treated cells, however,
had not yet formed distinguishable axon and dendrites at
the beginning of drug treatment. We wondered whether
the actin cytoskeleton was also responsible for the mainte-
nance of dendritic fate in later developmental stages.
Stage 3 cells show a clear morphological polarization, with
one axon and several dendrites, after 2 days in culture. We
therefore treated stage 3 neurons with cytochalasin D for
4 days (starting on day 2), and looked for the segregation of
Tau-1, GAP-43 and MAP-2. In contrast to control cells,
which restrict the axonal markers to one neurite, 69.5
(± 2.1)% of cytochalasin-D-treated neurons showed at least
two, and more commonly three to six, neurites containing
Tau-1 (n = 895). In addition, 83.0 (± 2.4)% of latrunculin-B-
treated cells (n = 994) showed multiple (2–6) Tau-1-posi-
tive neurites. Independent experiments showed that 68.2
(± 4.2)% of cytochalasin-D-treated neurons had two or more
neurites enriched in GAP-43 (n = 383) (data not shown).
To analyze this effect we carried out long-term observa-
tions of stage 3 cells kept in a closed chamber containing
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Figure 1
Axotomy of stage 4 cells induces
transformation of a dendrite into an axon.
(a) A stage 3 neuron grown on a gridded
coverslip showing the axon (black arrows) and
dendrites (white arrowheads). (b) Two days
later, the axon has grown further (white arrow)
and has acquired a mature axonal morphology,
being thin and cylindrically shaped from the
cell body onwards (black arrows). The
dendrites have grown and show their
characteristic tapered morphology
(arrowheads). (c) After cutting the axon (thick
arrow) the cell was put back into the original
medium. (d) One day after cutting, the former
axon had grown only 15 µm and had become
tapered. Phase-contast photo of the cell in (c)
showing that one dendrite (arrowheads)
drastically changed its morphology from
tapered (see b,c; arrowheads) to long, thin and
cylindrical. (e,f ) Fixation and immunostaining
with rabbit anti-MAP-2 antibody and
monoclonal Tau-1 antibody showed that the
cut axon (arrow) became (e) Tau-1 negative
and (f) MAP-2 positive. The dendrite that
changed its shape (arrowheads) is (e) Tau-1
positive distally and (f) MAP-2 positive close to
the cell body. (g) Merged image of phase-
contrast (blue), Tau-1 (green) and MAP-2 (red)
labeling from (d–f). Additional Tau-1-positive
axons in close proximity to the axotomized cell
body are numbered 1–3. See text for details.
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either DMSO, as control, or cytochalasin D. In control
cells the axon grew further whereas the minor neurites
remained quiescent [6,8]. This was not the case in cytocha-
lasin-D-treated neurons (see Supplementary material).
Minor neurites grew at rates normally achieved only by
the axon (see Supplementary material). Fixation and
staining showed that the fast-growing neurites contained
Tau-1 in their distal part whereas MAP-2 was restricted to
the proximal part (see Supplementary material). These
results imply that actin filament stability in the dendritic
growth cones is essential for restraining young dendrites
from becoming axons.
We next investigated whether dendrites at an even later
developmental stage, when axonal and dendritic proteins
have localized to their proper compartments, still require
an intact actin filament network to maintain their fate. We
treated stage 4 cells for 3 days with cytochalasin D (start-
ing on day 5) fixed and stained for MAP-2 and Tau-1.
Before adding the drug, coverslips of 5-day-old neurons
were fixed and the polarized distribution of MAP-2 and
Tau-1 confirmed (see Figure 2a–d) [5,7]. The addition of
cytochalasin D to stage 4 cells changed this phenotype
radically. Instead of a Tau-1-positive MAP-2-negative
axon and multiple Tau-1-negative MAP-2-positive den-
drites, 66.7 (± 4.3)% of cytochalasin-D-treated stage 4
neurons (n = 330) had multiple (2–6) neurites that were
MAP-2 positive only in their proximal region (Figure 3,
arrowhead) but Tau-1 positive distally (Figure 3, arrow).
This suggests that even molecularly differentiated den-
drites can grow as axons upon depletion of actin filaments,
implying a role for actin stability in the maintenance of
dendritic fate.
We conclude first, that axonal and dendritic commitments
are plastic and reversible events despite the existence of
morphologically (stage 3) and molecularly (stage 4) dis-
tinct axonal/dendritic domains [4,5,13]. Consistent with
our results, cutting neonatal rat motor neurons causes
sprouting from the cell body [14], and axotomy of spinal
motor neurons of adult cats induces an additional neurite
to form [15]. Second, axonal and dendritic fate appear to
depend on the state of the actin network in the growth
cones, irrespective of the degree of morphological or mole-
cular maturity of the cells. Whereas dendrites have the
potential to grow as axons, even when specific cytoskeletal
architecture and membrane-sorting pathways are fixed, a
functional actin cytoskeleton appears to restrain axonal
specification and growth, allowing only the single axon to
grow and mature as such. 
In agreement with our earlier data, Ruthel and Hollenbeck
[16] report enhanced growth rates of neurites in the pres-
ence of the actin-depolymerizing drug cytochalasin E. In
contrast to some of our results, they show that one neurite of
a stage 2 cell still grows faster than the other neurites and
that only one neurite becomes Tau-1 positive. The differ-
ences between their results and ours may be due to the
effects of the different drugs used. Consistent with this
idea, the small extensions of cytochalasin-E-treated neurons
are very thin and sparse in microtubules compared with the
axon [16]. This is a qualitative difference from minor neu-
rites of stage 3 control cells. The thin extensions Ruthel
and Hollenbeck describe are similar to the Tau-1-negative
MAP-2-negative thin extensions we observed beside the
multiple axons in the presence of cytochalasin D, toxin B or
latrunculin B (for example, the thin extension close to the
cell body in Figure 3, open arrowhead).
How could the actin cytoskeleton restrain dendrites from
becoming axons? Our results from multipolar hippocampal
neurons are consistent with the explanation of Forscher
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Figure 2
Cytochalasin-D-treated neurites contain
Tau-1 but are devoid of MAP-2 distally.
Unpolarized hippocampal neurons were
treated with (a–d) DMSO as control or
(e–h) 0.5 µM cytochalasin D for 5 days in
culture, fixed with paraformaldehyde and
stained with monoclonal Tau-1 antibody and
rabbit anti-MAP-2 antibody. In control cells,
the long axon (arrow) is (a) Tau-1 positive
and (b) MAP-2 negative. In contrast, the
dendrites (arrowhead) are (a) devoid of
Tau-1 but are (b) MAP-2 positive. (c) Phase-
contrast image of the cell. (d) Merged image
of Tau-1 (green), MAP-2 (red) and phase-
contrast (blue) from (a–c).(e,f) In
cytochalasin-D-treated cells the axonal
marker Tau-1 is (e) enriched in the neurites’
distal part (white arrow), which is devoid of
MAP-2 staining, whereas (f) the proximal
parts of all the neurites contain MAP-2
(arrowhead). (g) Phase-contrast image of
the cell. (h) Merged image of (e–g); colours
as in (d).
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and Smith [17] of the growth of Aplysia axons. They pro-
posed that the actin cytoskeleton, which is in the periph-
eral area of the growth cones of minor neurites and
dendrites, forms a dense network that sterically hinders
microtubules from protruding distally. In contrast, a more
dynamic and less stable actin cytoskeleton in the axonal
growth cone may be looser and more permissive for micro-
tubule protrusion. Actin depolymerization of MAP-2c-
transfected non-neuronal cells consistently causes process
formation [18]. In addition to the steric hindrance model,
proteins interacting with both microtubules and the actin
cytoskeleton, such as MAP-2 and ezrin [19], may control
microtubule protrusion. Thus, by changing the activity
of actin-binding proteins the stability and dynamics of the
actin cytoskeleton can be changed [20], which could then
govern microtubule protrusion.
Supplementary material
Supplementary material including detailed methodology and additional
experimental data is available at http://current-biology.com/supmat/
supmatin.htm. 
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Figure 3
Stage 4 neurons form multiple axons upon
actin depolymerization. (a–d) Stage 4 cells
were treated with 1 µM cytochalasin D for
3 days, fixed with paraformaldehyde and
stained with (a) monoclonal Tau-1 antibody
and (b) rabbit anti-MAP-2 antibody.
(c) Phase-contrast image of the cell.
(d) Merged image of (a–c). The distribution of
Tau-1 and MAP-2 appears complementary.
The neurites contain MAP-2 close to the cell
body (filled arrowhead) whereas distally, the
neurites are MAP-2 negative but Tau-1-
positive (arrow). The neurite marked with a
star also contains Tau-1 close to the cell body
and thus was likely to be the initial axon. The
open arrowhead indicates a thin Tau-1-
negative Map-2-negative thin extension. The
neurite marked with a star contains Tau-1
also close to the cell body and, hence, was
likely the initial axon.
Tau-1 (green) MAP-2 (red)
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